- Addressing
a global epidemic through the launch of Hygee
- Partnered
with communications agencies to raise brand awareness and increase
visibility
- Positioned
for success following a year filled with new achievements
According to the Centers for Disease Control (CDC), more
than two million cases of chlamydia, gonorrhea and syphilis were reported in
the United States in 2016. The majority (1.6 million) were newly-diagnosed
cases of chlamydia. Young women make up nearly half of all diagnosed chlamydia
cases. The CDC recommends that STD screening and timely treatment become a
standard part of medical care (http://ibn.fm/jQj7I). Decreasing the stigma of talking
about STDs is important in creating a culture that seeks out testing,
especially for pregnant women. Left untreated, chlamydia can lead to
miscarriages, premature birth or stillbirth, and it can be passed to the infant
during childbirth.
Earth Science Tech, Inc. (OTCQB: ETST) is strategically
positioning Hygee, a non-invasive discreet chlamydia testing kit, as the answer
to this global epidemic. The company announced earlier this month (http://ibn.fm/9Rg05) that it has
partnered with communication agencies Les Fous de la Com and Priori System to
build a strong online presence, create brand recognition and awareness, educate
consumers and develop partnerships and associations for increased visibility on
local, national and international levels.
“We are delighted to work with Earth Science in the
promotion of Hygee, as it stands to improve the quality of life of women
everywhere on the planet,” Priori System President Christian Dumont stated in the
news release. “The goal is to bring Hygee to women everywhere, making the
product and the service so well known that we can finally begin to ease the
catastrophe of Chlamydia and other sexually transmitted infections.”
Nickolas S. Tabraue, chairman of ETST, believes strongly in
the success of Hygee. While the company has the ability to turn the tide of the
chlamydia epidemic, it will take the support of governments and the medical
community to make this vision a reality. “This will work,” Tabraue noted in the
release, “because we will put Hygee in the hands of the women who need it. We
are going to give women control over their own testing, and their own bodies.
As confident as we are in our product, that is going to take a community, not a
company.”
Following a year filled with achievement, ETST is
strategically positioned for success in 2019. In 2018, ETST successfully:
- Became
fully reporting;
- Uplisted
to the OTCQB Venture Market;
- Improved
its High Grade Full Spectrum line;
- Increased
sales by more than 100 percent; and
- Ordered
the first batch of Hygee, which is expected to launch later this month.
As members of the management team reflected on the success
of 2018 (http://ibn.fm/X82K4),
they also shared their vision and excitement for the upcoming year. Overall,
the feeling is one of positive excitement as distribution and presence in the
marketplace increase, potential is realized and new opportunities await.
For more information, visit the company’s website at www.EarthScienceTech.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
